SpaceX Weekly Recap -4.2%: Nasdaq Entry Meets Warning
Can a Nasdaq-100 debut lift SpaceX, or is Wall Street already fixated on the company’s massive funding risk?
Can a Nasdaq-100 debut lift SpaceX, or is Wall Street already fixated on the company’s massive funding risk?
Can the S&P 500 keep climbing as AI leadership wobbles and oil shocks return to the inflation debate?
Can Micron’s $250 billion U.S. buildout outweigh fresh competitive pressure from SK Hynix and keep the AI memory trade intact?
Are Tesla Deliveries still just an auto metric, or have they become the market’s clearest signal for Tesla’s AI ambitions?
Could the Novo Nordisk Semaglutide Implant solve one of obesity treatment’s biggest problems: patients quitting before the drug can work?
Is Dell’s latest pullback a warning sign for the AI trade, or the kind of dip growth investors wait for?
Can Robinhood Forecast stay bullish after a -2.2% drop, or is Wall Street seeing a bigger crypto infrastructure story?
Can SpaceX still outrun global launch rivals as China closes the gap and investors punish execution risk?
Is the SanDisk Meta Deal the start of a lasting AI storage boom, or is Wall Street already pricing in perfection?
Can FuelCell Energy’s $225 million raise fund real growth, or did the market just price in a much tougher road ahead?